The study team compared Aquamin, a marine red-algae mineral extract, with calcium carbonate using a two-stage simulated gastric-to-intestinal digestion protocol. The authors reported that both mineral preparations were solubilized under acidic, gastric-like conditions. Aquamin resisted acid-mediated breakdown to a greater degree than calcium carbonate in these assays. When samples were transferred to neutral-pH, intestinal-like conditions most calcium remained in the soluble fraction; limited precipitation occurred overall. With Aquamin specifically, magnesium and strontium were detected primarily in soluble fractions after the pH transition. Several other trace cationic elements present in Aquamin became partially or fully insoluble under intestinal conditions, according to ICP-OES/ICP-MS quantification described in the paper. The source did not report detailed kinetic rates of precipitation or exact concentrations for every element beyond the qualitative solubility patterns described.
Light and scanning electron microscopy revealed rapid adherence of dispersed Aquamin particles to human colon epithelial cells. The investigators observed ultrafine Aquamin particles lodged between adjacent epithelial cells by transmission electron microscopy, indicating close apposition at the cell surface. By contrast, calcium carbonate demonstrated slower binding kinetics and attached to fewer cells in the same experimental setup. The authors noted these differences without reporting specific binding constants or quantitative measures of surface coverage; the data presented were descriptive microscopy observations and micrographs supporting particle localization and relative binding speed.
The study team used TMT-based proteomics to profile protein-level responses in colon epithelial organoids exposed to the mineral preparations. Aquamin exposure increased proteins associated with enterocyte cation uptake, intracellular trafficking pathways, and basolateral secretion mechanisms, investigators reported. These proteomic shifts align with an epithelial program favoring transcellular cation handling: enhanced uptake at the apical membrane, trafficking through cytosolic compartments, and secretion across the basolateral surface. The paper did not provide functional transport assays or electrophysiological measures that would directly quantify flux, so the proteomic data indicate molecular changes rather than definitive transport rates.
Serum samples collected from participants in 90- and 180-day Aquamin intervention trials were analyzed for changes in circulating cationic elements. The authors reported increased serum strontium levels after both 90 and 180 days of Aquamin consumption. Most other elements measured showed minimal changes in circulation; however, serum iron rose modestly. The source did not report participant-level demographics, exact participant counts, dosing regimens, or statistical values for these serum changes in the abstract and main summary; readers will need to consult the full preprint for granular trial metadata and the magnitude of reported changes.
Data indicated that soluble calcium, magnesium, and strontium present after simulated digestion are plausibly absorbed via transcellular pathways, the authors argued, supported by proteomic upregulation of enterocyte uptake and trafficking proteins. The study team also proposed that elements rendered less soluble during intestinal conditions might still cross the colonic epithelium through paracellular routes, particularly if particulate material or ultrafine particles interact with tight junction regions. The evidence for paracellular passage in this work is inferential—based on solubility profiles and particle localization—but direct measurements of paracellular permeability or tracer flux were not reported in the paper.
The authors declared that two contributors are affiliated with Marigot Inc.; other authors reported no competing interests. Several limitations were acknowledged implicitly by the methods and results: the simulated digestion system models but does not replicate the full complexity of the human gastrointestinal environment; proteomic changes were measured in organoids rather than in vivo intestinal tissue; and serum analyses were summarized without full trial metadata in the article abstract. The source did not report detailed dosing, participant numbers, or full statistical outputs in the summary provided. Key unanswered clinical questions remain: whether the proteomic changes translate to altered net mineral absorption in humans, how insoluble trace elements behave long-term in the colon, and what clinical outcomes—if any—result from sustained Aquamin consumption beyond biochemical changes. These specific next steps and precise trial metrics were not reported in the abstract and will require consultation of the full preprint for further detail.